Literature DB >> 9202275

Stenotrophomonas maltophilia meningitis. Report of two cases and review of the literature.

K A Papadakis1, S E Vartivarian, M E Vassilaki, E J Anaissie.   

Abstract

The authors report two cases of meningitis caused by Stenotrophomonas maltophilia in cancer patients following placement of an Ommaya reservoir for treatment of meningeal carcinomatosis. In addition, they review eight other cases of S. maltophilia that have been reported to date. Stenotrophomonas maltophilia meningitis is often associated with neurosurgical procedures; however, spontaneous infection may also occur, mainly in neonates. The disease's clinical presentation is similar to that of other forms of meningitis caused by Gram-negative bacilli. The overall mortality rate of this disease is 20% and is limited to neonates with spontaneous meningitis in whom effective antibiotic therapy is delayed. Meningitis caused by S. maltophilia in the modern era should be considered in immunocompromised hosts with significant central nervous system disease who have undergone neurosurgical procedures and who do not readily respond to broad-spectrum antimicrobial coverage.

Entities:  

Mesh:

Year:  1997        PMID: 9202275     DOI: 10.3171/jns.1997.87.1.0106

Source DB:  PubMed          Journal:  J Neurosurg        ISSN: 0022-3085            Impact factor:   5.115


  8 in total

1.  Multiple antibiotic resistance in Stenotrophomonas maltophilia: involvement of a multidrug efflux system.

Authors:  L Zhang; X Z Li; K Poole
Journal:  Antimicrob Agents Chemother       Date:  2000-02       Impact factor: 5.191

2.  Risk factors for mortality among patients with Stenotrophomonas maltophilia bacteremia in Tokyo, Japan, 1996-2009.

Authors:  H Araoka; M Baba; A Yoneyama
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2010-02-23       Impact factor: 3.267

3.  Stenotrophomonas (Xanthomonas) maltophilia infection in necrotizing pancreatitis.

Authors:  K E Mönkemüller; D E Morgan; T H Baron
Journal:  Int J Pancreatol       Date:  1999-02

4.  Antifolate activity of epigallocatechin gallate against Stenotrophomonas maltophilia.

Authors:  María Dolores Navarro-Martínez; Enma Navarro-Perán; Juan Cabezas-Herrera; Joaquín Ruiz-Gómez; Francisco García-Cánovas; José Neptuno Rodríguez-López
Journal:  Antimicrob Agents Chemother       Date:  2005-07       Impact factor: 5.191

5.  Isolation and characterization of novel giant Stenotrophomonas maltophilia phage phiSMA5.

Authors:  Hsiao-Chuan Chang; Chiy-Rong Chen; Juey-Wen Lin; Gwan-Han Shen; Kai-Ming Chang; Yi-Hsiung Tseng; Shu-Fen Weng
Journal:  Appl Environ Microbiol       Date:  2005-03       Impact factor: 4.792

Review 6.  Toxicity of treatment for neoplastic meningitis.

Authors:  Tali Siegal
Journal:  Curr Oncol Rep       Date:  2003-01       Impact factor: 5.075

Review 7.  Community-acquired Stenotrophomonas maltophilia infections: a systematic review.

Authors:  M E Falagas; A C Kastoris; E K Vouloumanou; G Dimopoulos
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2009-02-18       Impact factor: 3.267

8.  Stenotrophomonas maltophilia Meningitis - A Case Series and Review of the Literature.

Authors:  Iffat Khanum; Aisha Ilyas; Farheen Ali
Journal:  Cureus       Date:  2020-10-28
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.